Four of the last ten came late. The 2018 accounts came in latest, 43 days after the end of the period.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 17,817 companies had the same profile as Dr. ROXANE ROSSIGNOL has now. Each dot stands for 45 companies, two years later.
96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
Small
10 to 20 years old
solvency 30% or more
a profit of 5% of the balance sheet or more
Test of the method
The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 17,817 companies, not a prediction for Dr. ROXANE ROSSIGNOL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Purpose change · Amendment of the articles · Legal-form change · Resignations & appointmentsName hiddenVisible after signing in changes role from manager to director · “Toutes les recherches et toutes études en rapport avec son objet principal, s'occuper de la recherche et du…” (deed in French) · General meeting of 28-09-2022 · Gazette deed
Registered office moved from Brussels to Plancenoit
The registered office moved from rue de la Balsamine 48, 1120 Bruxelles to rue Mathy 12, 1380 Plancenoit · General meeting of 14-08-2013 · Gazette deed
Incorporation
Founding capital of €18,600, 186 shares · Founded by Hidden nameVisible after signing in · Name after signing inVisible after signing in appointed as manager · published on 26-01-2011 · Gazette deed
According to the KBO register, the main activity of the establishment unit is physiotherapy (NACE 86951).
What is the legal form of Dr. ROXANE ROSSIGNOL?
Dr. ROXANE ROSSIGNOL is a private limited company (BV).
When was Dr. ROXANE ROSSIGNOL founded?
Dr. ROXANE ROSSIGNOL was founded on 14-01-2011.
Is Dr. ROXANE ROSSIGNOL still active?
Yes, Dr. ROXANE ROSSIGNOL is an active enterprise in the KBO register.
What is the turnover of Dr. ROXANE ROSSIGNOL?
The turnover in financial year 2025 is about €250,000. This figure is estimated from the gross margin of €102,889 and 2,454 comparable companies of the same size. It probably lies between €170,000 and €400,000. It is a rough estimate.Financials
Is Dr. ROXANE ROSSIGNOL profitable?
In financial year 2025, Dr. ROXANE ROSSIGNOL made a profit of €36,217.
Where can I find the annual accounts of Dr. ROXANE ROSSIGNOL?
Dr. ROXANE ROSSIGNOL filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. ROXANE ROSSIGNOL due?
Dr. ROXANE ROSSIGNOL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline